ATE127798T1 - 5-sauerstoffhaltige hmg-co-a reduktase- inhibitoren. - Google Patents

5-sauerstoffhaltige hmg-co-a reduktase- inhibitoren.

Info

Publication number
ATE127798T1
ATE127798T1 AT89201642T AT89201642T ATE127798T1 AT E127798 T1 ATE127798 T1 AT E127798T1 AT 89201642 T AT89201642 T AT 89201642T AT 89201642 T AT89201642 T AT 89201642T AT E127798 T1 ATE127798 T1 AT E127798T1
Authority
AT
Austria
Prior art keywords
reductase inhibitors
oxygen containing
containing hmg
hmg
oxygen
Prior art date
Application number
AT89201642T
Other languages
English (en)
Inventor
Mark E Duggan
George D Hartman
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/250,646 external-priority patent/US4921974A/en
Priority claimed from US07/322,398 external-priority patent/US4963538A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE127798T1 publication Critical patent/ATE127798T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT89201642T 1988-06-29 1989-06-22 5-sauerstoffhaltige hmg-co-a reduktase- inhibitoren. ATE127798T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21301088A 1988-06-29 1988-06-29
US07/250,646 US4921974A (en) 1988-09-29 1988-09-29 Intermediates and processes in the preparation of 5-oxygenated HMG-COA reductase inhibitors
US07/322,398 US4963538A (en) 1988-06-29 1989-03-13 5-oxygenated HMG-CoA reductase inhibitors

Publications (1)

Publication Number Publication Date
ATE127798T1 true ATE127798T1 (de) 1995-09-15

Family

ID=27395805

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89201642T ATE127798T1 (de) 1988-06-29 1989-06-22 5-sauerstoffhaltige hmg-co-a reduktase- inhibitoren.

Country Status (14)

Country Link
EP (1) EP0349063B1 (de)
JP (1) JPH0253752A (de)
KR (1) KR910000694A (de)
AT (1) ATE127798T1 (de)
AU (1) AU619563B2 (de)
CA (1) CA1328876C (de)
DE (1) DE68924205T2 (de)
DK (1) DK319989A (de)
FI (1) FI893004L (de)
HU (1) HUT50803A (de)
IL (1) IL90781A0 (de)
NO (1) NO892677L (de)
NZ (1) NZ229671A (de)
PT (1) PT90958B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT88364A (pt) * 1987-09-02 1989-07-31 Merck & Co Inc Process for preparing novel hmg-coa reductase inhibitors
US5200549A (en) * 1988-11-14 1993-04-06 Hoffman-La Roche Inc. Antipsoriatic agents
US5073568A (en) * 1988-11-14 1991-12-17 Hoffmann-La Roche Inc. Antipsoriatic agents
CA2036962C (en) * 1990-02-26 1998-09-15 Ann E. Decamp Process for the desilylation of a 4-silyloxy-tetrahydro-pyran-2-one
US5059696A (en) * 1990-03-15 1991-10-22 Merck & Co., Inc. Processes and intermediates for the preparation of 5-oxygenated hmg-coa reductase inhibitors
MY106564A (en) * 1990-07-06 1995-06-30 Squibb & Sons Inc Sulfur-substituted mevinic acid derivatives.
US5286746A (en) * 1991-12-20 1994-02-15 E. R. Squibb & Sons, Inc. Sulfur-substituted mevinic acid derivatives
US5369123A (en) * 1992-10-09 1994-11-29 E. R. Squibb & Sons, Inc. Nitrogen-substituted mevinic acid derivatives useful as HMG-CoA reductase inhibitors
SI20159A (sl) * 1999-02-04 2000-08-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Nov postopek za odstranitev sililoksi zaščitne skupine iz 4-sililoksi tetrahidro-piran-2-on-ov
SI21187A (sl) * 2002-03-26 2003-10-31 Krka, Tovarna Zdravil D.D., Novo Mesto Postopek za pripravo 4-oksitetrahidropiran-2-onov
KR20200066690A (ko) 2017-10-16 2020-06-10 칭화대학교 메발로네이트 경로 억제제 및 이의 약제학적 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56150037A (en) * 1980-04-22 1981-11-20 Sankyo Co Ltd Hydronaphthalene compound
JPS58188872A (ja) * 1982-04-26 1983-11-04 Suntory Ltd オクタヒドロナフタレン誘導体及びその製造法
JPS59186972A (ja) * 1983-03-09 1984-10-23 Suntory Ltd オクタヒドロナフタレン誘導体並びにその製造法
US4668699A (en) * 1985-08-05 1987-05-26 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
PT85109A (en) * 1986-06-23 1987-07-01 Merck & Co Inc Process for the preparation of hydroxy-tetrahydropyranone derivatives or corresponding ring opened dihydroxy acids which are hmg-coa reductase inhibitors
PT88364A (pt) * 1987-09-02 1989-07-31 Merck & Co Inc Process for preparing novel hmg-coa reductase inhibitors

Also Published As

Publication number Publication date
DK319989A (da) 1990-01-02
FI893004A0 (fi) 1989-06-19
FI893004A7 (fi) 1989-12-30
KR910000694A (ko) 1991-01-30
DE68924205T2 (de) 1996-03-28
PT90958A (pt) 1989-12-29
JPH0253752A (ja) 1990-02-22
FI893004L (fi) 1989-12-30
DK319989D0 (da) 1989-06-28
NO892677L (no) 1990-01-02
AU3711689A (en) 1990-01-04
EP0349063B1 (de) 1995-09-13
HUT50803A (en) 1990-03-28
EP0349063A3 (en) 1990-05-09
AU619563B2 (en) 1992-01-30
IL90781A0 (en) 1990-01-18
CA1328876C (en) 1994-04-26
PT90958B (pt) 1994-11-30
NO892677D0 (no) 1989-06-27
DE68924205D1 (de) 1995-10-19
NZ229671A (en) 1991-11-26
EP0349063A2 (de) 1990-01-03

Similar Documents

Publication Publication Date Title
ES2101960T3 (es) Lactamas benzo-condensadas.
AU3509789A (en) Benzamide protease inhibitors
DK51087A (da) Antihypercholesterolaemiske forbindelser
ATE127798T1 (de) 5-sauerstoffhaltige hmg-co-a reduktase- inhibitoren.
ES2126697T3 (es) Inhibidores de enzimas de conversion de angiotensina que contienen lactamas de anillos multiples.
DK0747393T3 (da) Dobbeltvirkende inhibitorer indeholdende en thiazolobenzazepinstruktur
ES2044013T3 (es) Compuesto mesomorfico, una composicion de cristal liquido que contiene el compuesto y un dispositivo de cristal liquido que utiliza la composicion.
DE69834508D1 (de) Aptoptoseinhibitoren
ZA927606B (en) Antifungal agent.
AR247744A1 (es) Compuestos organosilano y catalizadores que contienen dichos compuestos
EP0332409A3 (de) Substituierte Naphthalen-Verbindungen und diese enthaltende Flüssigkristall-Zusammensetzungen
ES2179254T3 (es) 1-poliarilpirazoles plaguicidas.
ATE69050T1 (de) Organische verbindungen und ihre pharmazeutische verwendung.
MX170732B (es) Composicion de derivados de succinimida y su uso
ATE31295T1 (de) Benzoylharnstoffderivate.
GR3007465T3 (de)
EP0245003A3 (de) Antihypercholesterolemische Verbindungen
ES2068407T3 (es) Tratamiento de apneas durante el sueño con derivados de azapirona.
ATE135352T1 (de) 3-keto-hmg-coa reduktase-inhibitoren
NO943230L (no) Naftoksaziner
YU127289A (sh) INHIBITORI 5-OKSIGENISANE HMG-CoA REDUKTAZE
ATE138382T1 (de) Antitumor- und antivirale-verbindung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties